HEADER VIRAL PROTEIN/IMMUNE SYSTEM 19-MAR-21 7M42 TITLE COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS TITLE 2 OF NEUTRALIZING ANTIBODIES REGN10985 AND REGN10989 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REGN10989 ANTIBODY FAB FRAGMENT LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: REGN10989 ANTIBODY FAB FRAGMENT HEAVY CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: E; COMPND 12 FRAGMENT: RECEPTOR BINDING DOMAIN (UNP RESIDUES 319-541); COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 4; COMPND 15 MOLECULE: REGN10985 ANTIBODY FAB FRAGMENT LIGHT CHAIN; COMPND 16 CHAIN: C; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 5; COMPND 19 MOLECULE: REGN10985 ANTIBODY FAB FRAGMENT HEAVY CHAIN; COMPND 20 CHAIN: D; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 13 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 17 2; SOURCE 18 ORGANISM_COMMON: 2019-NCOV; SOURCE 19 ORGANISM_TAXID: 2697049; SOURCE 20 GENE: S, 2; SOURCE 21 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 22 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 24 MOL_ID: 4; SOURCE 25 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 26 ORGANISM_COMMON: HUMAN; SOURCE 27 ORGANISM_TAXID: 9606; SOURCE 28 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 29 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 30 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 31 MOL_ID: 5; SOURCE 32 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 33 ORGANISM_COMMON: HUMAN; SOURCE 34 ORGANISM_TAXID: 9606; SOURCE 35 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 36 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 37 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS SARS-COV-2, RBD, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM KEYWDS 2 COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Y.ZHOU,A.ROMERO HERNANDEZ,K.SAOTOME,M.C.FRANKLIN REVDAT 2 25-AUG-21 7M42 1 JRNL REVDAT 1 28-JUL-21 7M42 0 JRNL AUTH R.COPIN,A.BAUM,E.WLOGA,K.E.PASCAL,S.GIORDANO,B.O.FULTON, JRNL AUTH 2 A.ZHOU,N.NEGRON,K.LANZA,N.CHAN,A.COPPOLA,J.CHIU,M.NI,Y.WEI, JRNL AUTH 3 G.S.ATWAL,A.R.HERNANDEZ,K.SAOTOME,Y.ZHOU,M.C.FRANKLIN, JRNL AUTH 4 A.T.HOOPER,S.MCCARTHY,S.HAMON,J.D.HAMILTON,H.M.STAPLES, JRNL AUTH 5 K.ALFSON,R.CARRION JR.,S.ALI,T.NORTON,S.SOMERSAN-KARAKAYA, JRNL AUTH 6 S.SIVAPALASINGAM,G.A.HERMAN,D.M.WEINREICH,L.LIPSICH,N.STAHL, JRNL AUTH 7 A.J.MURPHY,G.D.YANCOPOULOS,C.A.KYRATSOUS JRNL TITL THE MONOCLONAL ANTIBODY COMBINATION REGEN-COV PROTECTS JRNL TITL 2 AGAINST SARS-COV-2 MUTATIONAL ESCAPE IN PRECLINICAL AND JRNL TITL 3 HUMAN STUDIES. JRNL REF CELL V. 184 3949 2021 JRNL REFN ISSN 1097-4172 JRNL PMID 34161776 JRNL DOI 10.1016/J.CELL.2021.06.002 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.300 REMARK 3 NUMBER OF PARTICLES : 146054 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7M42 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1000255613. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX OF SARS-COV-2 RECEPTOR REMARK 245 BINDING DOMAIN WITH THE FAB REMARK 245 FRAGMENTS OF NEUTRALIZING REMARK 245 ANTIBODIES REGN10985 AND REMARK 245 REGN10989 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1 REMARK 465 SER A 2 REMARK 465 THR A 213 REMARK 465 GLU A 214 REMARK 465 CYS A 215 REMARK 465 SER A 216 REMARK 465 SER B 225 REMARK 465 CYS B 226 REMARK 465 ASP B 227 REMARK 465 LYS B 228 REMARK 465 THR B 229 REMARK 465 ARG E 319 REMARK 465 VAL E 320 REMARK 465 GLN E 321 REMARK 465 PRO E 322 REMARK 465 THR E 323 REMARK 465 GLU E 324 REMARK 465 SER E 325 REMARK 465 ILE E 326 REMARK 465 VAL E 327 REMARK 465 ARG E 328 REMARK 465 PHE E 329 REMARK 465 PRO E 330 REMARK 465 ASN E 331 REMARK 465 ILE E 332 REMARK 465 LYS E 528 REMARK 465 LYS E 529 REMARK 465 SER E 530 REMARK 465 THR E 531 REMARK 465 ASN E 532 REMARK 465 LEU E 533 REMARK 465 VAL E 534 REMARK 465 LYS E 535 REMARK 465 ASN E 536 REMARK 465 LYS E 537 REMARK 465 CYS E 538 REMARK 465 VAL E 539 REMARK 465 ASN E 540 REMARK 465 PHE E 541 REMARK 465 GLU E 542 REMARK 465 GLN E 543 REMARK 465 LYS E 544 REMARK 465 LEU E 545 REMARK 465 ILE E 546 REMARK 465 SER E 547 REMARK 465 GLU E 548 REMARK 465 GLU E 549 REMARK 465 ASP E 550 REMARK 465 LEU E 551 REMARK 465 GLY E 552 REMARK 465 GLY E 553 REMARK 465 GLU E 554 REMARK 465 GLN E 555 REMARK 465 LYS E 556 REMARK 465 LEU E 557 REMARK 465 ILE E 558 REMARK 465 SER E 559 REMARK 465 GLU E 560 REMARK 465 GLU E 561 REMARK 465 ASP E 562 REMARK 465 LEU E 563 REMARK 465 HIS E 564 REMARK 465 HIS E 565 REMARK 465 HIS E 566 REMARK 465 HIS E 567 REMARK 465 HIS E 568 REMARK 465 HIS E 569 REMARK 465 GLN C 1 REMARK 465 THR C 215 REMARK 465 GLU C 216 REMARK 465 CYS C 217 REMARK 465 SER C 218 REMARK 465 LYS D 229 REMARK 465 SER D 230 REMARK 465 CYS D 231 REMARK 465 ASP D 232 REMARK 465 LYS D 233 REMARK 465 THR D 234 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASP A 52 N SER A 54 2.13 REMARK 500 OG SER A 65 OG1 THR A 76 2.14 REMARK 500 OG SER D 52 OG SER D 57 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 52 87.79 67.71 REMARK 500 VAL A 53 -2.32 -24.54 REMARK 500 SER A 54 -55.47 -134.31 REMARK 500 ALA A 86 -169.85 -161.09 REMARK 500 SER A 156 22.60 -140.67 REMARK 500 ASN B 108 30.31 -141.41 REMARK 500 ASP B 154 61.31 61.94 REMARK 500 ASN B 214 41.11 39.84 REMARK 500 ALA E 372 19.66 57.32 REMARK 500 PHE E 464 60.80 60.10 REMARK 500 ASN C 53 -3.68 66.15 REMARK 500 ALA C 86 -167.31 -161.66 REMARK 500 ASP C 144 61.82 61.29 REMARK 500 ASN C 176 -1.57 67.83 REMARK 500 TRP D 53 -6.71 68.45 REMARK 500 ASN D 113 -6.03 72.37 REMARK 500 SER D 145 33.45 -99.30 REMARK 500 ASP D 159 61.60 62.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-23662 RELATED DB: EMDB REMARK 900 COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB REMARK 900 FRAGMENTS OF NEUTRALIZING ANTIBODIES REGN10985 AND REGN10989 DBREF 7M42 A 1 216 PDB 7M42 7M42 1 216 DBREF 7M42 B 1 229 PDB 7M42 7M42 1 229 DBREF 7M42 E 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 DBREF 7M42 C 1 218 PDB 7M42 7M42 1 218 DBREF 7M42 D 1 234 PDB 7M42 7M42 1 234 SEQADV 7M42 GLU E 542 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLN E 543 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 LYS E 544 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 LEU E 545 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 ILE E 546 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 SER E 547 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLU E 548 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLU E 549 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 ASP E 550 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 LEU E 551 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLY E 552 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLY E 553 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLU E 554 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLN E 555 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 LYS E 556 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 LEU E 557 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 ILE E 558 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 SER E 559 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLU E 560 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 GLU E 561 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 ASP E 562 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 LEU E 563 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 HIS E 564 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 HIS E 565 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 HIS E 566 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 HIS E 567 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 HIS E 568 UNP P0DTC2 EXPRESSION TAG SEQADV 7M42 HIS E 569 UNP P0DTC2 EXPRESSION TAG SEQRES 1 A 216 GLN SER ALA LEU THR GLN PRO ALA SER VAL SER GLY SER SEQRES 2 A 216 PRO GLY GLN SER ILE THR ILE SER CYS THR GLY THR SER SEQRES 3 A 216 SER ASP VAL GLY THR TYR ASN TYR VAL SER TRP TYR GLN SEQRES 4 A 216 GLN HIS PRO GLY LYS ALA PRO LYS LEU MET ILE PHE ASP SEQRES 5 A 216 VAL SER ASN ARG PRO SER GLY VAL SER ASP ARG PHE SER SEQRES 6 A 216 GLY SER LYS SER GLY ASN THR ALA SER LEU THR ILE SER SEQRES 7 A 216 GLY LEU GLN ALA GLU ASP GLU ALA ASP TYR TYR CYS SER SEQRES 8 A 216 SER PHE THR THR SER SER THR VAL VAL PHE GLY GLY GLY SEQRES 9 A 216 THR LYS LEU THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SEQRES 10 A 216 SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 A 216 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 A 216 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SEQRES 13 A 216 SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER SEQRES 14 A 216 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 A 216 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 A 216 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 A 216 THR VAL ALA PRO THR GLU CYS SER SEQRES 1 B 229 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 B 229 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 B 229 TYR ILE PHE THR GLY TYR TYR MET HIS TRP VAL ARG GLN SEQRES 4 B 229 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY TRP ILE ASN SEQRES 5 B 229 PRO ASN SER GLY GLY ALA ASN TYR ALA GLN LYS PHE GLN SEQRES 6 B 229 GLY ARG VAL THR LEU THR ARG ASP THR SER ILE THR THR SEQRES 7 B 229 VAL TYR MET GLU LEU SER ARG LEU ARG PHE ASP ASP THR SEQRES 8 B 229 ALA VAL TYR TYR CYS ALA ARG GLY SER ARG TYR ASP TRP SEQRES 9 B 229 ASN GLN ASN ASN TRP PHE ASP PRO TRP GLY GLN GLY THR SEQRES 10 B 229 LEU VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 B 229 VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY SEQRES 12 B 229 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 B 229 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 B 229 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 B 229 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 B 229 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL SEQRES 17 B 229 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL SEQRES 18 B 229 GLU PRO LYS SER CYS ASP LYS THR SEQRES 1 E 251 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 E 251 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 3 E 251 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 E 251 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 5 E 251 SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 6 E 251 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 E 251 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 8 E 251 ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN SEQRES 9 E 251 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 E 251 TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN SEQRES 11 E 251 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 12 E 251 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 E 251 ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN SEQRES 14 E 251 CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR SEQRES 15 E 251 ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 E 251 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 E 251 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 E 251 ASN PHE GLU GLN LYS LEU ILE SER GLU GLU ASP LEU GLY SEQRES 19 E 251 GLY GLU GLN LYS LEU ILE SER GLU GLU ASP LEU HIS HIS SEQRES 20 E 251 HIS HIS HIS HIS SEQRES 1 C 218 GLN SER VAL LEU THR GLN PRO PRO SER VAL SER GLY ALA SEQRES 2 C 218 PRO GLY GLN ARG VAL THR ILE SER CYS THR GLY SER SER SEQRES 3 C 218 SER ASN ILE GLY ALA GLY TYR ASP VAL HIS TRP TYR GLN SEQRES 4 C 218 GLN LEU PRO GLY THR ALA PRO LYS LEU LEU ILE TYR GLY SEQRES 5 C 218 ASN SER ASN ARG PRO SER GLY VAL PRO ASP ARG PHE SER SEQRES 6 C 218 GLY SER LYS SER GLY THR SER ALA SER LEU ALA ILE THR SEQRES 7 C 218 GLY LEU GLN ALA GLU ASP GLU ALA ASP TYR TYR CYS GLN SEQRES 8 C 218 SER TYR ASP SER SER LEU SER GLY SER TYR VAL PHE GLY SEQRES 9 C 218 THR GLY THR LYS VAL THR VAL LEU GLY GLN PRO LYS ALA SEQRES 10 C 218 ALA PRO SER VAL THR LEU PHE PRO PRO SER SER GLU GLU SEQRES 11 C 218 LEU GLN ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER SEQRES 12 C 218 ASP PHE TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA SEQRES 13 C 218 ASP SER SER PRO VAL LYS ALA GLY VAL GLU THR THR THR SEQRES 14 C 218 PRO SER LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER SEQRES 15 C 218 TYR LEU SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SEQRES 16 C 218 SER TYR SER CYS GLN VAL THR HIS GLU GLY SER THR VAL SEQRES 17 C 218 GLU LYS THR VAL ALA PRO THR GLU CYS SER SEQRES 1 D 234 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 D 234 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 D 234 PHE THR PHE ASP ASP TYR ALA MET HIS TRP VAL ARG GLN SEQRES 4 D 234 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER GLY ILE SER SEQRES 5 D 234 TRP ASN ARG GLY SER ILE GLY TYR ALA ASP SER VAL LYS SEQRES 6 D 234 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS ASN SER SEQRES 7 D 234 LEU TYR LEU GLN MET SER SER LEU ARG ALA GLU ASP THR SEQRES 8 D 234 ALA LEU TYR TYR CYS ALA LYS ASP GLY GLU ARG TRP ASP SEQRES 9 D 234 SER VAL VAL VAL PRO SER ALA ARG ASN GLY MET ASP VAL SEQRES 10 D 234 TRP GLY GLN GLY THR THR VAL THR VAL SER SER ALA SER SEQRES 11 D 234 THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER SEQRES 12 D 234 LYS SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU SEQRES 13 D 234 VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP SEQRES 14 D 234 ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO SEQRES 15 D 234 ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER SEQRES 16 D 234 VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR SEQRES 17 D 234 TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS SEQRES 18 D 234 VAL ASP LYS LYS VAL GLU PRO LYS SER CYS ASP LYS THR HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 6 NAG 2(C8 H15 N O6) FORMUL 6 BMA C6 H12 O6 HELIX 1 AA1 GLN A 81 GLU A 85 5 5 HELIX 2 AA2 SER A 125 ALA A 131 1 7 HELIX 3 AA3 THR A 185 HIS A 192 1 8 HELIX 4 AA4 ILE B 28 THR B 30 5 3 HELIX 5 AA5 SER B 166 ALA B 168 5 3 HELIX 6 AA6 SER B 196 GLN B 202 1 7 HELIX 7 AA7 PHE E 338 ASN E 343 1 6 HELIX 8 AA8 SER E 349 TRP E 353 5 5 HELIX 9 AA9 ASP E 364 LEU E 368 5 5 HELIX 10 AB1 SER E 383 ASP E 389 1 7 HELIX 11 AB2 ASP E 405 ILE E 410 5 6 HELIX 12 AB3 GLY E 416 ASN E 422 1 7 HELIX 13 AB4 GLY E 502 TYR E 505 5 4 HELIX 14 AB5 SER C 127 ALA C 133 1 7 HELIX 15 AB6 THR C 187 SER C 193 1 7 HELIX 16 AB7 SER D 171 ALA D 173 5 3 HELIX 17 AB8 SER D 202 LEU D 204 5 3 SHEET 1 AA1 5 SER A 9 GLY A 12 0 SHEET 2 AA1 5 THR A 105 VAL A 109 1 O THR A 108 N VAL A 10 SHEET 3 AA1 5 ASP A 87 PHE A 93 -1 N TYR A 88 O THR A 105 SHEET 4 AA1 5 SER A 36 GLN A 40 -1 N GLN A 40 O ASP A 87 SHEET 5 AA1 5 LYS A 47 ILE A 50 -1 O LYS A 47 N GLN A 39 SHEET 1 AA2 4 SER A 9 GLY A 12 0 SHEET 2 AA2 4 THR A 105 VAL A 109 1 O THR A 108 N VAL A 10 SHEET 3 AA2 4 ASP A 87 PHE A 93 -1 N TYR A 88 O THR A 105 SHEET 4 AA2 4 VAL A 99 PHE A 101 -1 O VAL A 100 N SER A 92 SHEET 1 AA3 3 SER A 17 THR A 23 0 SHEET 2 AA3 3 THR A 72 SER A 78 -1 O LEU A 75 N ILE A 20 SHEET 3 AA3 3 PHE A 64 LYS A 68 -1 N SER A 67 O SER A 74 SHEET 1 AA4 4 SER A 118 PHE A 122 0 SHEET 2 AA4 4 ALA A 134 PHE A 143 -1 O LEU A 139 N THR A 120 SHEET 3 AA4 4 TYR A 176 LEU A 184 -1 O LEU A 184 N ALA A 134 SHEET 4 AA4 4 VAL A 163 THR A 165 -1 N GLU A 164 O TYR A 181 SHEET 1 AA5 4 SER A 118 PHE A 122 0 SHEET 2 AA5 4 ALA A 134 PHE A 143 -1 O LEU A 139 N THR A 120 SHEET 3 AA5 4 TYR A 176 LEU A 184 -1 O LEU A 184 N ALA A 134 SHEET 4 AA5 4 SER A 169 LYS A 170 -1 N SER A 169 O ALA A 177 SHEET 1 AA6 4 SER A 157 VAL A 159 0 SHEET 2 AA6 4 THR A 149 ALA A 154 -1 N ALA A 154 O SER A 157 SHEET 3 AA6 4 TYR A 195 HIS A 201 -1 O GLN A 198 N ALA A 151 SHEET 4 AA6 4 SER A 204 VAL A 210 -1 O VAL A 206 N VAL A 199 SHEET 1 AA7 4 GLN B 3 GLN B 6 0 SHEET 2 AA7 4 SER B 17 SER B 25 -1 O SER B 25 N GLN B 3 SHEET 3 AA7 4 THR B 78 SER B 84 -1 O MET B 81 N VAL B 20 SHEET 4 AA7 4 VAL B 68 ASP B 73 -1 N THR B 69 O GLU B 82 SHEET 1 AA8 6 GLU B 10 LYS B 12 0 SHEET 2 AA8 6 THR B 117 VAL B 121 1 O THR B 120 N GLU B 10 SHEET 3 AA8 6 ALA B 92 ARG B 101 -1 N TYR B 94 O THR B 117 SHEET 4 AA8 6 TYR B 32 GLN B 39 -1 N TYR B 33 O GLY B 99 SHEET 5 AA8 6 LEU B 45 ILE B 51 -1 O ILE B 51 N MET B 34 SHEET 6 AA8 6 ALA B 58 TYR B 60 -1 O ASN B 59 N TRP B 50 SHEET 1 AA9 4 SER B 130 LEU B 134 0 SHEET 2 AA9 4 THR B 145 TYR B 155 -1 O LEU B 151 N PHE B 132 SHEET 3 AA9 4 TYR B 186 PRO B 195 -1 O VAL B 194 N ALA B 146 SHEET 4 AA9 4 VAL B 173 THR B 175 -1 N HIS B 174 O VAL B 191 SHEET 1 AB1 4 THR B 141 SER B 142 0 SHEET 2 AB1 4 THR B 145 TYR B 155 -1 O THR B 145 N SER B 142 SHEET 3 AB1 4 TYR B 186 PRO B 195 -1 O VAL B 194 N ALA B 146 SHEET 4 AB1 4 VAL B 179 LEU B 180 -1 N VAL B 179 O SER B 187 SHEET 1 AB2 3 THR B 161 TRP B 164 0 SHEET 2 AB2 3 TYR B 204 HIS B 210 -1 O ASN B 209 N THR B 161 SHEET 3 AB2 3 THR B 215 VAL B 221 -1 O VAL B 217 N VAL B 208 SHEET 1 AB3 5 LYS E 356 ILE E 358 0 SHEET 2 AB3 5 VAL E 395 ARG E 403 -1 O VAL E 395 N ILE E 358 SHEET 3 AB3 5 PRO E 507 SER E 514 -1 O VAL E 512 N ASP E 398 SHEET 4 AB3 5 GLY E 431 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 5 AB3 5 THR E 376 TYR E 380 -1 N TYR E 380 O GLY E 431 SHEET 1 AB4 2 LEU E 452 ARG E 454 0 SHEET 2 AB4 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AB5 2 TYR E 473 GLN E 474 0 SHEET 2 AB5 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SHEET 1 AB6 5 SER C 9 GLY C 12 0 SHEET 2 AB6 5 THR C 107 VAL C 111 1 O THR C 110 N VAL C 10 SHEET 3 AB6 5 ALA C 86 SER C 92 -1 N TYR C 88 O THR C 107 SHEET 4 AB6 5 VAL C 35 GLN C 40 -1 N GLN C 40 O ASP C 87 SHEET 5 AB6 5 LYS C 47 ILE C 50 -1 O LYS C 47 N GLN C 39 SHEET 1 AB7 4 SER C 9 GLY C 12 0 SHEET 2 AB7 4 THR C 107 VAL C 111 1 O THR C 110 N VAL C 10 SHEET 3 AB7 4 ALA C 86 SER C 92 -1 N TYR C 88 O THR C 107 SHEET 4 AB7 4 VAL C 102 PHE C 103 -1 O VAL C 102 N SER C 92 SHEET 1 AB8 3 VAL C 18 THR C 23 0 SHEET 2 AB8 3 SER C 72 ILE C 77 -1 O ALA C 73 N CYS C 22 SHEET 3 AB8 3 PHE C 64 SER C 69 -1 N SER C 65 O ALA C 76 SHEET 1 AB9 4 SER C 120 PHE C 124 0 SHEET 2 AB9 4 ALA C 136 PHE C 145 -1 O LEU C 141 N THR C 122 SHEET 3 AB9 4 TYR C 178 LEU C 186 -1 O ALA C 180 N ILE C 142 SHEET 4 AB9 4 VAL C 165 THR C 167 -1 N GLU C 166 O TYR C 183 SHEET 1 AC1 4 SER C 120 PHE C 124 0 SHEET 2 AC1 4 ALA C 136 PHE C 145 -1 O LEU C 141 N THR C 122 SHEET 3 AC1 4 TYR C 178 LEU C 186 -1 O ALA C 180 N ILE C 142 SHEET 4 AC1 4 SER C 171 LYS C 172 -1 N SER C 171 O ALA C 179 SHEET 1 AC2 4 SER C 159 VAL C 161 0 SHEET 2 AC2 4 VAL C 150 ALA C 156 -1 N ALA C 156 O SER C 159 SHEET 3 AC2 4 TYR C 197 HIS C 203 -1 O GLN C 200 N ALA C 153 SHEET 4 AC2 4 SER C 206 VAL C 212 -1 O VAL C 212 N TYR C 197 SHEET 1 AC3 3 LEU D 18 ALA D 23 0 SHEET 2 AC3 3 SER D 78 MET D 83 -1 O LEU D 81 N LEU D 20 SHEET 3 AC3 3 THR D 69 ASP D 73 -1 N THR D 69 O GLN D 82 SHEET 1 AC4 5 ILE D 58 TYR D 60 0 SHEET 2 AC4 5 LEU D 45 SER D 52 -1 N GLY D 50 O GLY D 59 SHEET 3 AC4 5 ALA D 33 GLN D 39 -1 N TRP D 36 O SER D 49 SHEET 4 AC4 5 ALA D 92 LYS D 98 -1 O TYR D 95 N VAL D 37 SHEET 5 AC4 5 THR D 122 VAL D 124 -1 O THR D 122 N TYR D 94 SHEET 1 AC5 4 SER D 135 LEU D 139 0 SHEET 2 AC5 4 THR D 150 TYR D 160 -1 O LEU D 156 N PHE D 137 SHEET 3 AC5 4 TYR D 191 PRO D 200 -1 O SER D 195 N CYS D 155 SHEET 4 AC5 4 VAL D 178 THR D 180 -1 N HIS D 179 O VAL D 196 SHEET 1 AC6 4 THR D 146 SER D 147 0 SHEET 2 AC6 4 THR D 150 TYR D 160 -1 O THR D 150 N SER D 147 SHEET 3 AC6 4 TYR D 191 PRO D 200 -1 O SER D 195 N CYS D 155 SHEET 4 AC6 4 VAL D 184 LEU D 185 -1 N VAL D 184 O SER D 192 SHEET 1 AC7 3 THR D 166 TRP D 169 0 SHEET 2 AC7 3 TYR D 209 HIS D 215 -1 O ASN D 214 N THR D 166 SHEET 3 AC7 3 THR D 220 VAL D 226 -1 O LYS D 224 N CYS D 211 SSBOND 1 CYS A 22 CYS A 90 1555 1555 2.03 SSBOND 2 CYS A 138 CYS A 197 1555 1555 2.03 SSBOND 3 CYS B 22 CYS B 96 1555 1555 2.03 SSBOND 4 CYS B 150 CYS B 206 1555 1555 2.03 SSBOND 5 CYS E 336 CYS E 361 1555 1555 2.03 SSBOND 6 CYS E 379 CYS E 432 1555 1555 2.03 SSBOND 7 CYS E 391 CYS E 525 1555 1555 2.03 SSBOND 8 CYS E 480 CYS E 488 1555 1555 2.03 SSBOND 9 CYS C 22 CYS C 90 1555 1555 2.03 SSBOND 10 CYS C 140 CYS C 199 1555 1555 2.04 SSBOND 11 CYS D 22 CYS D 96 1555 1555 2.03 SSBOND 12 CYS D 155 CYS D 211 1555 1555 2.04 LINK ND2 ASN E 343 C1 NAG F 1 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.45 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.45 CISPEP 1 TYR A 144 PRO A 145 0 -0.07 CISPEP 2 ASP B 111 PRO B 112 0 -0.59 CISPEP 3 PHE B 156 PRO B 157 0 -3.00 CISPEP 4 GLU B 158 PRO B 159 0 -3.59 CISPEP 5 TYR C 146 PRO C 147 0 -0.70 CISPEP 6 PHE D 161 PRO D 162 0 -3.70 CISPEP 7 GLU D 163 PRO D 164 0 -4.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000